CoChat

Defining the phenotypic spectrum of SLC6A1 mutations

Open access
Johannesen, Katrine M., Gardella, Elena, Linnankivi, Tarja, Courage, Carolina, de Saint Martin, Anne, Lehesjoki, Anna‐Elina, Mignot, Cyril, Afenjar, Alexandra, Lesca, Gaetan, Abi‐Warde, Marie‐Thérèse, Chelly, Jamel, Piton, Amélie, Merritt, J. Lawrence, Rodan, Lance H., Tan, Wen‐Hann, Bird, Lynne M., Nespeca, Mark, Gleeson, Joseph G., Yoo, Yongjin, Choi, Murim, Chae, Jong‐Hee, Czapansky‐Beilman, Desiree, Reichert, Sara Chadwick, Pendziwiat, Manuela, Verhoeven, Judith S., Schelhaas, Helenius J., Devinsky, Orrin, Christensen, Jakob, Specchio, Nicola, Trivisano, Marina, Weber, Yvonne G., Nava, Caroline, Keren, Boris, Doummar, Diane, Schaefer, Elise, Hopkins, Sarah, Dubbs, Holly, Shaw, Jessica E., Pisani, Laura, Myers, Candace T., Tang, Sha, Tang, Shan, Pal, Deb K., Millichap, John J., Carvill, Gemma L., Helbig, Kathrine L., Mecarelli, Oriano, Striano, Pasquale, Helbig, Ingo, Rubboli, Guido, Mefford, Heather C., Møller, Rikke S. · 2018 · Epilepsia
Cited by 150

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Summary: Objective: Pathogenic SLC6A1 variants were recently described in patients with myoclonic atonic epilepsy (MAE) and intellectual disability (ID). We set out to define the phenotypic spectrum in a larger cohort of SCL6A1‐mutated patients. Methods: We collected 24 SLC6A1 probands and 6 affected family members. Four previously published cases were included for further electroclinical description. In total, we reviewed the electroclinical data of 34 subjects. Results: Cognitive development was impaired in 33/34 (97%) subjects; 28/34 had mild to moderate ID, with language impairment being the most common feature. Epilepsy was diagnosed in 31/34 cases with mean onset at 3.7 years. Cognitive assessment before epilepsy onset was available in 24/31 subjects and was normal in 25% (6/24), and consistent with mild ID in 46% (11/24) or moderate ID in 17% (4/24). Two patients had speech delay only, and 1 had severe ID. After epilepsy onset, cognition deteriorated in 46% (11/24) of cases. The most common seizure types were absence, myoclonic, and atonic seizures. Sixteen cases fulfilled the diagnostic criteria for MAE. Seven further patients had different forms of generalized epilepsy and 2 had focal epilepsy. Twenty of 31 patients became seizure‐free, with valproic acid being the most effective drug. There was no clear‐cut correlation between seizure control and cognitive outcome. Electroencephalography (EEG) findings were available in 27/31 patients showing irregular bursts of diffuse 2.5‐3.5 Hz spikes/polyspikes‐and‐slow waves in 25/31. Two patients developed an EEG pattern resembling electrical status epilepticus during sleep. Ataxia was observed in 7/34 cases. We describe 7 truncating and 18 missense variants, including 4 recurrent variants (Gly232Val, Ala288Val, Val342Met, and Gly362Arg). Significance: Most patients carrying pathogenic SLC6A1 variants have an MAE phenotype with language delay and mild/moderate ID before epilepsy onset. However, ID alone or associated with focal epilepsy can also be observed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/epi.13986

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 17

  1. 10.1007/s11064-014-1494-9 · DOI
  2. 10.3389/fendo.2013.00165 · DOI · Paper page
  3. 10.3389/fncel.2014.00161 · DOI · Paper page
  4. 10.1038/nm.2058 · DOI · Paper page
  5. 10.1002/ajmg.a.36761 · DOI · Paper page
  6. 10.1016/S0140-6736(12)61480-9 · DOI · Paper page
  7. 10.1038/gim.2015.155 · DOI
  8. 10.1097/00004691-200311000-00007 · DOI · Paper page
  9. 10.1111/epi.13670 · DOI · Paper page
  10. 10.1017/neu.2015.37 · DOI
  11. 10.1016/j.pnpbp.2017.04.015 · DOI
  12. Doose H, 1992, Myoclonic‐astatic epilepsy, Epilepsy Res Suppl., 6, 163
  13. 10.1111/epi.13222 · DOI · Paper page
  14. 10.1016/j.ajhg.2008.04.020 · DOI · Paper page
  15. 10.1111/j.1469-1809.2006.00332.x · DOI
  16. 10.1016/S0387-7604(01)00281-9 · DOI
  17. 10.1155/2010/479364 · DOI · Paper page

Cited by

See all 150

Metadata

Authors
Johannesen, K. M., Gardella, E., Linnankivi, T., Courage, C., de Saint Martin, A., Lehesjoki, A., Mignot, C., Afenjar, A., Lesca, G., Abi‐Warde, M., Chelly, J., Piton, A., Merritt, J. L., Rodan, L. H., Tan, W., Bird, L. M., Nespeca, M., Gleeson, J. G., Yoo, Y., Choi, M., Chae, J., Czapansky‐Beilman, D., Reichert, S. C., Pendziwiat, M., Verhoeven, J. S., Schelhaas, H. J., Devinsky, O., Christensen, J., Specchio, N., Trivisano, M., Weber, Y. G., Nava, C., Keren, B., Doummar, D., Schaefer, E., Hopkins, S., Dubbs, H., Shaw, J. E., Pisani, L., Myers, C. T., Tang, S., Tang, S., Pal, D. K., Millichap, J. J., Carvill, G. L., Helbig, K. L., Mecarelli, O., Striano, P., Helbig, I., Rubboli, G., Mefford, H. C., & Møller, R. S.
Venue
Epilepsia
Publisher
Wiley
Published
2018-01-08
Volume
59
Issue
2
Pages
389-402
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W2783266079
Cited by
150
References
3
FWCI
9.71
Type
journal article
Language
en
Open access
gold
Funders
  • Deutsche Forschungsgemeinschaft (We4896/3‐1, He5415/6‐1)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Defining the phenotypic spectrum of SLC6A1 mutations. https://app.cochat.ai/papers/10.1111/epi.13986
The paper
Johannesen, K. M., Gardella, E., Linnankivi, T., Courage, C., de Saint Martin, A., Lehesjoki, A., Mignot, C., Afenjar, A., Lesca, G., Abi‐Warde, M., Chelly, J., Piton, A., Merritt, J. L., Rodan, L. H., Tan, W., Bird, L. M., Nespeca, M., Gleeson, J. G., Yoo, Y., . . . Møller, R. S. (2018). Defining the phenotypic spectrum of SLC6A1 mutations. Epilepsia. https://doi.org/10.1111/epi.13986

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.